• Skip to main content
  • Skip to footer
  • UCI
  • Office of the Provost
  • Academic Initiatives
Donate
Follow IDSI on Twitter!
id science logo
  • Research
  • Publications
  • About Us
    • Leadership & Staff
    • Faculty Advisory Board
    • Affiliate Faculty
    • Contact Us
  • News
  • Events
  • Education & Training
  • Funding Opportunities
  • Resources
    • Coronavirus Disease (COVID-19) Outbreak Resources

HIV, HBV, HCV testing up among Medicaid enrollees, although missed opportunities remain.

You are here: Home / Uncategorized / HIV, HBV, HCV testing up among Medicaid enrollees, although missed opportunities remain.

January 9, 2023

Testing for HIV, hepatitis B, and hepatitis C increased among U.S. Medicaid enrollees initiating treatment for opioid use disorder. However, a recent study showed approximately three-quarters of enrollees were not tested for each condition.

“Limited information exists about testing for HIV, hepatitis B virus, and hepatitis C virus among persons enrolled in Medicaid who are starting medication treatment for their opioid use disorder, despite guidelines recommending such testing,” Katherine Ahrens, PhD, epidemiologist and assistant research professor in the Public Health Program at the University of Southern Maine Muskie School of Public Service, told Healio. “Testing for these conditions is recommended because past or current injection drug use is common among persons starting medication treatment for opioid use disorder (MOUD), and highly effective treatments exist for all three diseases that lower the risk of subsequent morbidity, prevent disease transmission, and are cost-saving.”

Read More

Uncategorized

Footer

Coronavirus Disease (COVID-19) Outbreak Resources

COVID-19

Resources

medical technology

Research

map of the world

Publications

magnifying glass
Get In Touch!

Office of Academic Planning
535 Aldrich Hall
University of California, Irvine
Irvine, CA 92697-1000

idinitiative@uci.edu

 

 

About Us

UCI Infectious Disease Science Initiative aims to position UCI as a global leader in research and education in infectious disease dynamics by fueling the development of new knowledge and insights into the dynamics of infectious diseases and drug resistance.

© 2019 UC Regents  |  Privacy Policy